Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot-Assisted surgery for kids: a safer option?

NCT ID NCT07530133

Disease control Sponsor: Hangzhou Kangji Weijing Medical Robotics Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new robotic system designed to help surgeons perform chest and belly surgeries in children. It will include 64 kids under 18 who need common surgeries like kidney repair or lung removal. The goal is to see if the robot is safe and works as well as standard surgery, with fewer complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 0 to 18 years old (excluding 18 years old), gender is not restricted. * Subjects with indications for pediatric thoracic and abdominal laparoscopic surgery and medically fit for laparoscopic procedures. * Legally authorized representative provides written informed consent; subject assent is obtained when the subject is developmentally capable. Exclusion Criteria: * Previous laparoscopic or open surgery at the target site, deemed unsuitable for laparoscopic surgery by the investigator. * Thoracic/abdominal/pelvic infection, peritonitis, diaphragmatic hernia, or severe systemic infection, deemed unsuitable for laparoscopic surgery. * Severe bleeding tendency or coagulopathy (APTT \> 1.5× upper limit of normal); long-term use of anticoagulants or antiplatelet agents, or such medications not discontinued for at least 1 week preoperatively (prophylactic low-molecular-weight heparin excluded). * Severe cardiovascular or circulatory disease incompatible with surgery. * Epilepsy or cognitive impairment. * Suspected or confirmed drug addiction. * Pregnancy. * Participation in another interventional device clinical trial within 1 month or a drug clinical trial within 3 months prior to enrollment. * Intraoperative findings that preclude laparoscopic surgery (e.g., severe adhesions, anatomical variation, poor exposure). * Other conditions deemed unsuitable by the investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Choledochal cyst resection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bile duct cyst gas bloat syndrome Hirschsprung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Choledochal cyst resection Congenital or acquired surgical conditions requiring minimally invasive surgery in children Fundoplication Indications for laparoscopic thoracic and abdominal surgery in children Ovarian tumor resection Pulmonary segmentectomy Pyeloplasty Radical operation for Hirschsprung disease Ureteral reimplantation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Children's Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310052, China

  • The Second Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325027, China

  • Wuhan Children's Hospital

    Wuhan, Hubei, 430016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.